145 related articles for article (PubMed ID: 32852335)
1. Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
Ye L; Zhang C; Seidensticker M; Mayerle J; Reiter FP; De Toni EN
Am J Gastroenterol; 2020 Dec; 115(12):2114-2116. PubMed ID: 32852335
[No Abstract] [Full Text] [Related]
2. The effect of radiation therapy on the objective response and outcomes with nivolumab for hepatocellular carcinoma.
Smith WH; Law AS; Hulkower M; McGee HM; Lehrer EJ; Schwartz M; Taouli B; Sung M; Buckstein M
Acta Oncol; 2020 Aug; 59(8):940-943. PubMed ID: 32441551
[No Abstract] [Full Text] [Related]
3. Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma.
Yu JI; Lee SJ; Lee J; Lim HY; Paik SW; Yoo GS; Choi C; Park HC
Cancer Med; 2019 Nov; 8(16):6986-6994. PubMed ID: 31588679
[TBL] [Abstract][Full Text] [Related]
4. A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: A Case Report.
Stotts MJ; Adjapong O; Kaplan DE
Hepatology; 2019 Oct; 70(4):1477-1479. PubMed ID: 31004512
[No Abstract] [Full Text] [Related]
5. Nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis: Safety and clinical outcomes in a retrospective case series.
Kambhampati S; Bauer KE; Bracci PM; Keenan BP; Behr SC; Gordan JD; Kelley RK
Cancer; 2019 Sep; 125(18):3234-3241. PubMed ID: 31154669
[TBL] [Abstract][Full Text] [Related]
6. Nivolumab for the treatment of hepatocellular carcinoma.
Chiew Woon L; Joycelyn Jie Xin L; Su Pin C
Expert Opin Biol Ther; 2020 Jul; 20(7):687-693. PubMed ID: 32249635
[TBL] [Abstract][Full Text] [Related]
7. Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis.
Yau T; Hsu C; Kim TY; Choo SP; Kang YK; Hou MM; Numata K; Yeo W; Chopra A; Ikeda M; Kuromatsu R; Moriguchi M; Chao Y; Zhao H; Anderson J; Cruz CD; Kudo M
J Hepatol; 2019 Sep; 71(3):543-552. PubMed ID: 31176752
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Locoregional Treatment during Immunotherapy with Nivolumab for Hepatocellular Carcinoma: A Retrospective Study of 41 Interventions in 29 Patients.
Marinelli B; Cedillo M; Pasik SD; Charles D; Murthy S; Patel RS; Fischman A; Ranade M; Bishay V; Nowakowski S; Sung M; Marron T; Lookstein R; Schwartz M; Kim E
J Vasc Interv Radiol; 2020 Nov; 31(11):1729-1738.e1. PubMed ID: 33012649
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic efficacy of combined radiation and percutaneous ethanol injection therapy in liver cell carcinoma--a case report].
Kishimoto H; Nakamura Y; Ohba Y; Tsuzuki H; Ito K; Inukai M; Yamada H; Kurokawa T; Sobue M
Nihon Shokakibyo Gakkai Zasshi; 1994 Apr; 91(4):928-32. PubMed ID: 8170064
[No Abstract] [Full Text] [Related]
10. Preserved Liver Transplant After PD-1 Pathway Inhibitor for Hepatocellular Carcinoma.
Varkaris A; Lewis DW; Nugent FW
Am J Gastroenterol; 2017 Dec; 112(12):1895-1896. PubMed ID: 29215617
[No Abstract] [Full Text] [Related]
11. Joining the dots for better liver cancer treatment.
Chan LK; Ng IO
Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):74-75. PubMed ID: 31712772
[No Abstract] [Full Text] [Related]
12. Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.
Finkelmeier F; Czauderna C; Perkhofer L; Ettrich TJ; Trojan J; Weinmann A; Marquardt JU; Vermehren J; Waidmann O
J Cancer Res Clin Oncol; 2019 Jan; 145(1):253-259. PubMed ID: 30374657
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of anti-PD-1 therapy in a patient with brain metastasis of parotid carcinoma: A case report.
Takemoto K; Miyahara N; Chikuie N; Hamamoto T; Ishino T; Ueda T; Takeno S
Auris Nasus Larynx; 2019 Oct; 46(5):813-817. PubMed ID: 30442438
[TBL] [Abstract][Full Text] [Related]
14. Case of complete response to neoadjuvant therapy using nivolumab in a patient with metastatic renal cell carcinoma.
Ikarashi D; Kato Y; Katagiri H; Takahara T; Uesugi N; Shiomi E; Sugimura J; Nitta H; Sugai T; Obara W
Int J Urol; 2018 Jun; 25(6):630-632. PubMed ID: 29693280
[TBL] [Abstract][Full Text] [Related]
15. Multiple Cranial Neuropathies From Nivolumab in a Patient With Metastatic Hepatocellular Carcinoma.
Siegel CH; Finn RS; Ho MG
Mayo Clin Proc; 2018 Apr; 93(4):540-541. PubMed ID: 29622100
[No Abstract] [Full Text] [Related]
16. Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma.
Nakahara Y; Fukui T; Shirasawa M; Harada S; Kusuhara S; Takakura A; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Masuda N; Inukai M; Sekiguchi T; Naoki K
Intern Med; 2018 Nov; 57(21):3149-3152. PubMed ID: 29877291
[TBL] [Abstract][Full Text] [Related]
17. Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide.
Rios A; Cen P; Dinh B; Mays SR; Patel AB
Eur J Cancer; 2019 Jan; 107():97-99. PubMed ID: 30554075
[No Abstract] [Full Text] [Related]
18. Treatment of advanced primary hepatocellular carcinoma by 131-I-anti-AFP.
Liu YK; Yang KZ; Wu YD; Gang YQ; Zhu DN
Lancet; 1983 Mar; 1(8323):531-2. PubMed ID: 6186874
[No Abstract] [Full Text] [Related]
19. Recent progress in the treatment of hepatocellular carcinoma.
Roh MS
Curr Opin Oncol; 1990 Aug; 2(4):725-30. PubMed ID: 1965691
[No Abstract] [Full Text] [Related]
20. Amazing result of Nivolumab in a patient with multiple carcinoma.
Manno S; Cicione A; Dell'Atti L; Giudice TD
J BUON; 2019; 24(2):865-867. PubMed ID: 31128053
[No Abstract] [Full Text] [Related]
[Next] [New Search]
